We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

TriLink to Open New Early Phase Therapeutic Manufacturing Facility

News   May 27, 2014

 
TriLink to Open New Early Phase Therapeutic Manufacturing Facility
 
 
Advertisement
 

RELATED ARTICLES

Algorithms Uncover Cancers’ Unseen Genetic Losses and Gains

News

Scientists have created new mathematical tools that allow scientists to search the vast collection of DNA snippets and uncover whether there are either missing pieces or duplicates. These algorithms, dubbed HATCHet and CHISEL, could help to improve diagnosis and treatment.

READ MORE

Portable 90-Minute COVID-19 Test CovidNudge Matches Labs for Accuracy

News

Since the emergence of the novel coronavirus SARS-CoV-2, scientists, physicians and key workers have all been calling for more rapid diagnostic testing. A new study from Imperial College London details a device that can give test results in just 90 minutes.

READ MORE

Team Identifies Potential Pitfall in Emerging Treatment for Cancer and Inflammation

News

Whilst studying an emerging drug target in cancer and inflammation, researchers discovered the unintended activation of a protein called ERK5, this activation was due to the binding location of the inhibitors. ERK5 inhibitors that bound to the kinase domain of the protein led to the protein being shuttled to the cell nucleus and activated. Blocking ERK5 has therapeutic potential, but activating it could have undesirable consequences in terms of stimulated unwanted cell growth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE